Litcius/Paper detail

Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma

Hari K. Rachamala, Naga Malleswara Rao Nakka, Ramcharan Singh Angom, Santanu Bhattacharya, Krishnendu Pal, Debabrata Mukhopadhyay

2024Gastroenterology12 citationsDOIOpen Access PDF

Topics & Concepts

Pancreatic ductal adenocarcinomaCancer researchMedicineDual (grammatical number)TransporterPancreatic cancerPharmacologyOncologyInternal medicineChemistryCancerGeneBiochemistryArtLiteratureCancer, Hypoxia, and MetabolismPancreatic and Hepatic Oncology ResearchCancer Research and Treatments
Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma | Litcius